Alembic gets USFDA nod for generic drug

Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor tablets, 90 mg, aimed at preventing heart attack and stroke. They also received tentative approval for the 60 mg version. The approved drug is equivalent to AstraZeneca's Brilinta, with the 90 mg tablet having a market size of over USD 1 billion.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2xhg1db
via IFTTT